Adaptimmune Alternatives & Competitors
12 companies similar to Adaptimmune — Designing and delivering cell therapies to transform the lives of people with ca...
Companies similar to Adaptimmune
Legend Biotech
Multinational biopharmaceutical company focused on discovering and developing cutting-edge...
Somerset, United States
Adicet Bio, Inc
A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...
Redwood City, United Stat...
Autolus Therapeutics
Focused on the development of precisely targeted, controlled & highly active T cell therap...
London, United Kingdom
Kite Pharma
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
Santa Monica, United Stat...
Track all Adaptimmune competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
San Diego, United States
Gracell Biotechnologies
A Member of the AstraZeneca Group
Shanghai, China
Adendra Therapeutics
Translating dendritic cell biology into new therapies for cancer and autoimmunity.
London, United Kingdom
Neogene Therapeutics
Pushing the frontier by pioneering next-generation engineered T cell receptor therapies fo...
Amsterdam, The Netherland...
Be Biopharma
Engineered B cells as medicines
Cambridge, United States
Iovance Biotherapeutics, Inc.
Iovance is a patient-centric, collaborative organization that is driven to change the way...
San Carlos, United States
Tessa Therapeutics Ltd
A clinical-stage biotech company developing autologous and allogeneic cell therapies for t...
Singapore, Singapore
Immunocore
Science to Transform Lives
Abingdon, United Kingdom
About Adaptimmune
Adaptimmune stands as a pioneering entity in the biopharmaceutical landscape, specializing in cell therapies designed to revolutionize cancer treatment. With its strong presence in four biotechnology hubs across the U.K. and U.S., the company showcases comprehensive competencies ranging from preclinical research to com...
Development of T-cell therapies, Pipeline management of cell therapies, Sale and licensing of cell therapies, Biotechnological research, Clinical trials
Cancer patients, Healthcare professionals, Biopharmaceutical companies, Medical researchers
Cell Therapy, Cancer Treatment, T Cell Therapies, Preclinical Research, Clinical Development, Translational Sciences, Autologous Manufacturing, Allogeneic Manufacturing, T Cell Receptor Proteins, Affinity T Cell Receptor, Immunotherapy, Infectious Disease Treatment, HIV Therapy, Corporate Operations
B2B, B2D
Product Sales, Licensing, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Adaptimmune and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Adaptimmune on 11 Mar 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 29 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
